A Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage Non-Small Cell Lung Cancer (ROSETTA Lung-220) (clinicaltrials.gov) - Oct 14, 2026 - P2 | N=80 | Not yet recruiting | Sponsor: Bristol-Myers Squibb
New P2 trial • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • PD-L1
|